OptimizeRx Corp’s recently made public that its CEO FEBBO WILLIAM J acquired Company’s shares for reported $0.1 million on Dec 12 ’24. In the deal valued at $5.01 per share,20,000 shares were bought. As a result of this transaction, FEBBO WILLIAM J now holds 601,253 shares worth roughly $2.89 million.
RBC Capital Mkts downgraded its OptimizeRx Corp [OPRX] rating to a Sector perform from a an Outperform in a research note published on January 08, 2025; the price target was decreased to $6 from $7. A number of analysts have revised their coverage, including Stephens’s analysts, who began to cover the stock in mid December with a ‘”an Equal-weight”‘ rating. JMP Securities started covering the stock on April 04, 2024. It rated OPRX as “a Mkt outperform”.
Price Performance Review of OPRX
On Friday, OptimizeRx Corp [NASDAQ:OPRX] saw its stock fall -1.13% to $4.80. Over the last five days, the stock has lost -10.35%. OptimizeRx Corp shares have fallen nearly -1.13% since the year began. Nevertheless, the stocks have fallen -68.37% over the past one year. While a 52-week high of $16.65 was reached on 01/07/25, a 52-week low of $3.78 was recorded on 01/08/25. SMA at 50 days reached $5.14, while 200 days put it at $8.27.
Levels Of Support And Resistance For OPRX Stock
The 24-hour chart illustrates a support level at 4.67, which if violated will result in even more drops to 4.54. On the upside, there is a resistance level at 4.98. A further resistance level may holdings at 5.16. The Relative Strength Index (RSI) on the 14-day chart is 43.65, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.30, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 89.49%. Stochastics %K at 15.10% indicates the stock is a buying.
How much short interest is there in OptimizeRx Corp?
A steep rise in short interest was recorded in OptimizeRx Corp stocks on 2024-12-31, growing by 0.23 million shares to a total of 1.24 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 1.0 million shares. There was a rise of 18.9%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on January 03, 2024 when Barclays began covering the stock and recommended ‘”an Equal weight”‘ rating along with a $15 price target.
